Research Article: Development and validation of a radiomics-based prediction pipeline for the response to stereotactic radiosurgery therapy in brain metastases
Abstract:
The first treatment strategy for brain metastases (BM) plays a pivotal role in the prognosis of patients. Among all strategies, stereotactic radiosurgery (SRS) is considered a promising therapy method. Therefore, we developed and validated a radiomics-based prediction pipeline to prospectively identify BM patients who are insensitive to SRS therapy, especially those who are at potential risk of progressive disease.
No summary available.